Skip to main content

Table 4 Summary of characteristics of the studies

From: Family planning behaviours among women with diabetes mellitus: a scoping review

Author, year

Country

Title

Study objectives

Study design

Study setting

Study population and sample size (n)

Falsetti et al. [54]

United States

Condom Use, Pregnancy and STDs in Adolescent Females with and without Type 1 DM

To describe and compare adolescent females with and without diabetes in terms of use of condoms, pregnancy outcomes and sexually transmitted disease outcome

Case–control study

Multicentre – 4 major university-based diabetic clinics

Adolescent females aged 16 to 22 years old with T1DM and without diabetes (n = 132)

Chuang et al. [37]

United States

Contraceptive Use by Diabetic and obese women

To describe contraceptive use by diabetic and overweight/obese women compared to women without these conditions

Cross-sectional—surveillance system

11 states (Family Planning Module of the Behavioral Risk Factor Surveillance System)

Sexually active women aged 18–44 who were not trying to conceive (n = 7,943)

Diabetes and Pregnancy Group, [63]

France

Knowledge about preconception care in French women with type 1 diabetes

To assess the knowledge about preconception care among wmen with T1DM of childbearing age

Cross-sectional study

Multicentre – 11 Diabetes Centres

women of childbearing age with T1DM (n = 138)

Napoli et al. [61]

Italy

Contraception in diabetic women: an Italian study

To determine the pattern of contraception used by diabetic women in relation to their sociocultural background

Cross-sectional study

12 centres throughout the country

Fertile women with T1DM &T2DM (n = 667)

Charron-Prochownik et al. [35]

United States

Knowledge, attitudes and behaviors related to sexuality and family planning in adolescent women with and without diabetes

To examine knowledge, attitudes, intentions, and behaviours regarding diabetes and reproductive issues, sexual activity, and birth control in teens with diabetes in relation to a non-diabetic group

Case–control study

Multisite – 4 major universities

Adolescents aged 16–23 years old with diabetes and without diabetes (n = 117)

Shawe et al. [57]

United Kingdom

Use of hormonal contraceptive methods by women with diabetes

To establish use of hormonal contraception in UK women aged between 15 and 44 years with T1DM or T2DM compared with comparison groups with no DM

Cross-sectional study

General practice database across UK

Women with diabetes aged 15 to 44 years old (n = 1,312)

Mazaheri et al. [59]

Iran

Pattern of Contraceptive Use in Diabetic Women

To determine the patterns of contraceptive use among diabetic women referring to Ardabil Medical Sciences University in Iran

Cross-sectional study

Diabetes clinic of a university hospital (referral centre)

Women with diabetes aged 15–49 years (n = 100)

Vahratian et al. [51]

United States

Family-Planning Practices Among Women with Diabetes and Overweight and Obese Women in the 2002 National Survey for Family Growth

To examine contraceptive practices among diabetic women and obese women

Population survey

Nationwide survey National Survey for Family Growth

Women 20–44 years old (n = 5,955)

Schwarz et al. [49]

United States

Perceived access to contraception among adolescents with diabetes—barriers to preventing pregnancy complications

To assess beliefs, perceived access to, and practices regarding contraception among adolescent women with T1DM

Cross-sectional study

2 university-based diabetes centres

T1DM aged 13–19 years old from endocrinology practices (n = 89)

Schwarz et al. [48]

United States

Provision of Contraceptive Services to Women with Diabetes Mellitus

To compare rates of provision of contraceptive services among women with DM and women without chronic medical conditions

Retrospective cohort study

Integrated managed care organization in Northern California

15–44 years old women who had continuous membership and pharmacy benefits in a managed care organisation (n = 459,181) (8,182 women with diabetes)

Shawe et al. [58]

United Kingdom

Use of contraception by women with type 1 or type 2 diabetes mellitus: ‘ It’s funny that nobody really spoke to me about it’

1) To understand factors which promote or discourage use of contraception in women with DM 2) To identify contraceptive knowledge, skills and attitudes of health professionals involved in diabetes care

Mixed-method study

4 diabetes centres

Women aged 16 – 44 years with DM (n = 107 for quantitative, n = 16 for qualitative)

Manaf et al. [54]

Malaysia

Contraceptive Use among Women with Chronic Medical Conditions and Factors Associated with Its Non-Use in Malaysia

To describe contraceptive use among women with chronic medical conditions and factors associated with its non-use

Cross-sectional study

3 medical specialist outpatient clinic in hospitals and 8 health clinics

Women with chronic medical conditions aged 18–50 years old (n = 450)

Charron-Prochownik et al. [36]

United States

Long-Term Effects of the Booster-Enhanced READY-Girls Preconception Counseling Program on Intentions and Behaviors for Family Planning in Teens with Diabetes

To examine 12-month effects of a booster-enhanced preconception counselling program (READY-Girls) on family planning for teen girls with T1DM and T2DM

Randomised controlled trial

Multicentre – 2 University hospitals diabetic clinics

Adolescent girls between 13 and < 20 years of age with either T1DM or T2DM for > 1 year (n = 109)

Nojomi et al. [60]

Iran

Contraceptive use by Iranian women with hypertension, diabetes or obesity

To determine the pattern of contraception use by women with DM, hypertension or obesity

Cross-sectional survey

Single centre – outpatient clinic of a university hospital

Women aged 18 to 53 years old with T2DM, hypertension or overweight/obesity (N = 264)

Perritt et al. [45]

United States

Contraception counseling, pregnancy intention and contraception use in women with medical problems: an analysis of data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS)

To evaluate whether women with selected medical comorbidities are less likely than healthier women to report receiving contraceptive counselling during pregnancy and to report using contraception postpartum

Retrospective analysis from monitoring system survey

State-wide survey—Maryland Pregnancy Risk Assessment Monitoring System (PRAMS)

Postpartum women (n = 6,361)

DeNoble et al. [38]

United States

Receipt of Prescription Contraception by Commercially Insured Women with Chronic Medical Conditions

To assess differences in receipt of prescription contraception among women with and without chronic medical conditions

Retrospective study

Insurance claim records

Women aged 21 to 45 years old with medical condition, enrolled in commercial insurance company (n = 11,649)

Champaloux et al. (2015) [34]

United States

Contraceptive use among women with medical conditions in a nationwide privately insured population

To examine contraceptive use among women with selected medical conditions

Retrospective study

Nationwide healthcare claim database

Women aged 15 to 44 years old (n = 368,448) (10,903 with diabetes mellitus)

Mekonnen et al. [65]

Ethiopia

Contraceptive use in women with hypertension and diabetes: cross-sectional study in northwest Ethiopia

To assess contraceptive use and associated factors among diabetic and hypertensive women of reproductive age on chronic follow-up care at University of Gondar and Felege Hiwot Hospitals

Cross-sectional study

2 university hospitals

Women with diabetes and hypertension aged 15–49 years old (n = 392)

Osman et al. [64]

South Africa

Reproductive knowledge and use of contraception among women with diabetes

To assess the reproductive knowledge and use of contraception in women of reproductive age attending diabetes outpatient clinics

Prospective study

3 diabetic outpatient clinics

Women with diabetes mellitus aged 18 to 45 years old (n = 115)

Klingensmith et al. (2016) [43]

United States

Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience

To evaluate pregnancy outcomes during the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study

Retrospective study

15 paediatric diabetes care clinics and practices

Youths aged 10–17 years old with Type 2 DM who participated in a RCT who reported pregnancies (n = 46)

Phillips Bell et al. [46]

United States

Chronic Diseases and Use of Contraception Among Women at Risk of Unintended Pregnancy

To assess whether three common chronic diseases (DM, cardiovascular disease, or asthma) were associated with use of contraception, according to various levels of effectiveness

Surveillance system data

State-wide surveillance—Florida Behavioral Risk Factor Surveillance System

Women aged 18–44 years old (n = 4,473)

Sereika et al. (2016) [50]

United States

Operationalizing and Examining Family Planning Vigilance in Adult Women With Type 1 Diabetes

To operationalize and describe Family Planning Vigilance (FPV) and examine the associations among FPV behaviours and diabetes self-care management (DSM) and health outcomes of women with T1DM

Retrospective cohort study

A university hospital

Women with T1DM who previously participated in adolescents’ preconception program (n = 102)

Schwarz et al. [47]

United States

Postpartum Care and Contraception provided to Women with Gestational and Preconception Diabetes in California’s Medicaid Program

To compare rates of postpartum care and contraception provided to women with gestational or preconception DM to women with no known DM

Retrospective cohort study

Medicaid claims state-wide

Women aged 15 to 44 years old under Medicaid program (n = 199,860)

Hibbert et al. [62]

Australia

Preconception care and contraceptive use among Australian women with diabetes mellitus

To explore preconception care practices and contraception use among women with DM

Cross-sectional survey

Tertiary referral centre

16–49 years old women with T1DM or T2DM (n = 215)

Britton et al. [25]

United States

Contraceptive use among women with prediabetes and diabetes in a US national sample

To estimate the relationship between contraceptive use and key measures of glucose dysregulation among women of reproductive age in a US national sample

Cross-sectional study

National Longitudinal Study of Adolescent to Adult Health

Sexually active women aged 24 to 32 years old (n = 5,548)

Law et al. [52]

Malaysia

Influences on the decision to use contraception among Sarawakian women with diabetes: a qualitative exploration

To explore the reasons for contraceptive use among Sarawakian women with DM

Qualitative study – in-depth interviews

A public primary care clinic

Sexually active, adult, pre-menopausal females (aged ≥ 18) with T2DM (n = 12)

Morris et al. [44]

United States

Description and comparison of postpartum use of effective contraception among women with and without diabetes

To describe contraceptive use and compare the effectiveness of contraceptive methods among postpartum women with and without DM

Cross-sectional study

Population-based data from the Pregnancy Risk Assessment Monitoring System (PRAMS)

Women who had recent live birth within 2–4 months (n = 93,754)

Britton et al. [33]

United States

Perceptions and Behaviors Related to Contraceptive Use in the Postpartum Period Among Women with Pregestational Diabetes Mellitus

To describe perceptions and behaviours related to contraception and preconception care and to test the association between these perceptions and contraceptive use in the postpartum period among women with pregestational DM

Cross-sectional study

Multicentre – 3 high-risk obstetric clinics

Postpartum women with diabetes mellitus (n = 55)

Disney et al. [39]

United States

Preconception counseling, contraceptive counselling, and long acting reversible contraception use in women with Type 1 diabetes: a retrospective cohort study

To describe the frequency of preconception counselling, contraceptive counselling, and LARC use by provider type and disease severity in reproductive age women with T1DM

Retrospective cohort study

Tertiary referral centre – data from Utah Enterprise Data Warehouse (EDW)

Women (16–49 years old) with T1DM (n = 541)

Hunter-greaves et al. [66]

Jamaica

Contraceptive practices in women with chronic medical conditions

To determine the contraceptive use in women with medical conditions at the University Hospital of the West Indies (UHWI)

Cross-sectional study

Single centre—medical outpatient departments in a university hospital

Females with various chronic medical conditions aged 18 to 44 years old (n = 260)

Leow et al. [53]

Malaysia

Patient perception of pre-pregnancy are and family planning among reproductive age female diabetes mellitus patients in a primary care clinic in Penang, Malaysia

To assess female diabetic patients’ perception of PPC and family planning prior to Pre-pregnancy care (PPC) care

Cross-sectional study

A public primary care clinic

Women with diabetes mellitus aged 18–45 years old (n = 67)

Horwitz et al. [42]

United States

Use of contraception before and after a diabetes diagnosis: An observational matched cohort study

To determine how a DM diagnosis affects contraception use

Retrospective cohort study

Using private insurance data from a large national private health insurance provider)

Non-pregnant women aged 15–49 years (n = 75,355 with diabetes, n = 7.5 million without diabetes)

Scott et al. [56]

United Kingdom

Pregnancy and contraception in women with Pre-Gestational diabetes in secondary Care– A questionnaire study

To establish the knowledge of women with pre-gestational DM about of the risks of diabetes in pregnancy, and investigate their pregnancy plans, contraceptive choices, and preparedness for pregnancy

Cross-sectional study

Multicentre—Diabetes clinics across a single NHS Trust

Women of reproductive age with diabetes mellitus (n = 96)

Feutry et al. [41]

United States

Contraception use and knowledge related to pregnancy in diabetic women

To assess diabetic patients’ knowledge about pregnancy and to describe their contraceptive use

Observational study

Single centre – university hospital

Women aged 18 to 40 years old with diabetes mellitus (n = 89)